Zebra coalition petitions FDA

February 4, 2014

A petition spearheaded by the Zebra Coalition, brought together by MPNforum, asks that the FDA require a Patient Advocate be available at every Investigative New Drug clinical trial site to provide a needed level of Patient safety. The Patient Advocate would be empowered to communicate directly with Patients and with Investigators on behalf of Patients.

This initiative comes in the wake of the November 2013 announcement by Sanofi that they are discontinuing drug trials for their compound SAR302503 (Fedratinib) which was found to have neuro-toxicity for patients on the trial.

READ MORE OR SIGN THE PETITION

Receive updates on the latest MPN news & events.

Find out ways you can help support MPN patients and researchers.

x

NEVER MISS AN UPDATE

Get free, timely information on living with an MPN.

Subscribe